Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Wei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9262-849X; OpenAlex author ID A5100452051. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1+CD8+ T Cells in Patients Failing First-line Chemotherapy in Stage IV… Co-author DOI 10.1158/2767-9764.crc-23-0137↗
  2. IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/0008-5472.can-16-0438↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoyan Zhang · 1 shared paper, 2023 · strength 0.17
  2. Jing Wang · 1 shared paper, 2023 · strength 0.17
  3. Jianqing Xu · 1 shared paper, 2023 · strength 0.17
  4. Huamin Wang · 1 shared paper, 2016 · strength 0.05
  5. Song Gao · 1 shared paper, 2016 · strength 0.05
  6. Paul J. Chiao · 1 shared paper, 2016 · strength 0.05
  7. Jihui Hao · 1 shared paper, 2016 · strength 0.05
  8. Jason B. Fleming · 1 shared paper, 2016 · strength 0.05
  9. He Ren · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.